The problem

High volume. Short staffing. Zero margin for error.

The global shortage of qualified laboratory personnel in clinical and anatomical pathology is deeply entrenched. Combined with rising case volumes and a shrinking pathologist pipeline, every gross bench is under pressure - and tumor staging has no margin for error.

~24,000

Open U.S. clinical laboratory positions as of 2022.

10-25%

Average to peak vacancy rates across pathology labs worldwide.

Global

Work visas are insufficient - every country is competing for the same talent.

Stage-defining

One missed optimal section can shift a tumor's stage and change the treatment plan.

Working with AI

Built to work alongside intelligent tooling.

PathLogix treats AI as a partner at the bench - not a replacement for trained expertise. A dynamic checklist listens, prompts and captures the gross description as the specialist works, so every measurement, section and observation lands in a structured, standardized record.

Because the bench, the checklist and the model all follow the same standard, the data flowing downstream is consistent, auditable and ready for the next generation of staging intelligence - without ever taking the human out of the loop.

Where PathLogix fits

Standardize the bench, then layer the AI.

We pair a PA-led education network with a dynamic, voice-driven checklist system - so labs get a consistent standard at the gross bench and an AI co-pilot trained on that same standard.